| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/05/2013 | US8389698 Tanaproget derivatives, metabolites, and uses thereof |
| 03/05/2013 | US8389661 Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs |
| 03/05/2013 | US8389583 Antimicrobial compositions and methods of use |
| 03/05/2013 | US8389581 Compositions and methods for treating hoof diseases |
| 03/05/2013 | US8389580 Arylcyclopropylamines and methods of use |
| 03/05/2013 | US8389579 Biocide compositions (I) |
| 03/05/2013 | US8389578 Composition and method for treating neurological disease |
| 03/05/2013 | US8389577 Method of treating a human being for a class of metabolic defects and energy production disorders |
| 03/05/2013 | US8389574 Method useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| 03/05/2013 | US8389573 Glycyrrhetinic acid derivatives |
| 03/05/2013 | US8389572 Therapeutic delivery of carbon monoxide |
| 03/05/2013 | US8389571 Benzofuran derived HIV protease inhibitors |
| 03/05/2013 | US8389570 Hydroxamates as therapeutic agents |
| 03/05/2013 | US8389569 Polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same |
| 03/05/2013 | US8389568 IDO inhibitors and methods of use thereof |
| 03/05/2013 | US8389567 Compounds that modulate intracellular calcium |
| 03/05/2013 | US8389566 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 03/05/2013 | US8389565 Glycosidase inhibitors and methods of synthesizing same |
| 03/05/2013 | US8389564 Proteasome inhibitors |
| 03/05/2013 | US8389563 C-substituted diindolylmethane compositions and methods for the treatment of multiple cancers |
| 03/05/2013 | US8389562 Polymorphic forms of a 3-pyrrole substituted 2-indolinone |
| 03/05/2013 | US8389561 Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions |
| 03/05/2013 | US8389560 HCV protease inhibitors |
| 03/05/2013 | US8389559 Pyrrolidine triple reuptake inhibitors |
| 03/05/2013 | US8389558 Bendamustine amphiphilic anionic compositions |
| 03/05/2013 | US8389557 Triazole derivatives useful as Axl inhibitors |
| 03/05/2013 | US8389556 Thiazolidinedione analogues |
| 03/05/2013 | US8389555 Medicaments |
| 03/05/2013 | US8389554 Imidazothiadiazole derivatives |
| 03/05/2013 | US8389553 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| 03/05/2013 | US8389552 (S)-6-(2-(4-(cyclobutylsulfonyl)-1H-imidazol-1-yl)-3-cyclopentylpropanamido)nicotinic acid useful as a glucokinase activator |
| 03/05/2013 | US8389551 Optical enantiomers of phenyramidol and process for chiral synthesis |
| 03/05/2013 | US8389550 Isoxazoles / O-pyridines with ethyl and ethenyl linker |
| 03/05/2013 | US8389549 Substituted pyridines useful for treating pain |
| 03/05/2013 | US8389548 Administering an estrogen receptor for treatment of osteoporosis, breast cancer, hypercholesteremia, hyperlipidemia or artheriosclerosis by administering estrogen modulators |
| 03/05/2013 | US8389547 Piperidines and related compounds for the treatment of Alzheimer's disease |
| 03/05/2013 | US8389546 Compounds for modulating TRPV3 function |
| 03/05/2013 | US8389545 Quinolone M1 receptor positive allosteric modulators |
| 03/05/2013 | US8389544 Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 |
| 03/05/2013 | US8389543 Metalloenzyme inhibitor compounds |
| 03/05/2013 | US8389542 Dosage unit comprising a prostaglandin analog for treating constipation |
| 03/05/2013 | US8389540 Polymorphic solvates of naltrexone with ethanol, benzyl alcohol, dimethylformamide, methanol, dichloromethane, acetone and hexane; sustained release formulations |
| 03/05/2013 | US8389539 Azacyclic derivatives |
| 03/05/2013 | US8389538 Rexinoid compound having alkoxy group |
| 03/05/2013 | US8389537 Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 03/05/2013 | US8389536 Positive allosteric modulators (PAM) |
| 03/05/2013 | US8389535 L-methylfolate treatment for psychiatric or neurologic disorders |
| 03/05/2013 | US8389534 Pyrimidine non-classical cannabinoid compounds and related methods of use |
| 03/05/2013 | US8389533 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors |
| 03/05/2013 | US8389532 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine |
| 03/05/2013 | US8389531 Process for erlotinib hydrochloride |
| 03/05/2013 | US8389530 Substituted quinazoline compounds |
| 03/05/2013 | US8389529 Methods and compositions for treating asthma |
| 03/05/2013 | US8389526 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
| 03/05/2013 | US8389525 Small molecules for inhibition of protein kinases |
| 03/05/2013 | US8389524 Tricyclic nitrogen containing compounds as antibacterial agents |
| 03/05/2013 | US8389523 Substituted quinoxaline and an agrochemical composition thereof |
| 03/05/2013 | US8389522 Modulators of aldehyde dehydrogenase and methods of use thereof |
| 03/05/2013 | US8389521 Inhibitors of protein kinases |
| 03/05/2013 | US8389520 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases |
| 03/05/2013 | US8389519 Adamantyl diamide derivatives and uses of same |
| 03/05/2013 | US8389518 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 03/05/2013 | US8389517 Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
| 03/05/2013 | US8389516 Antibacterial compositions |
| 03/05/2013 | US8389515 2,4-pyrimidinediamine compounds and prodrugs and their uses |
| 03/05/2013 | US8389514 Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
| 03/05/2013 | US8389513 2-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides |
| 03/05/2013 | US8389512 In vivo studies of crystalline forms of meloxicam |
| 03/05/2013 | US8389511 Bicyclic heterocyclic derivative |
| 03/05/2013 | US8389510 Crystalline forms |
| 03/05/2013 | US8389509 Substituted pyrazole compounds |
| 03/05/2013 | US8389508 Heterocyclic compounds |
| 03/05/2013 | US8389507 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands |
| 03/05/2013 | US8389506 Compounds for therapy and diagnosis |
| 03/05/2013 | US8389505 Adamantane derivatives of AZA-crown ethers and their use in treatment of tumor |
| 03/05/2013 | US8389504 Prenatal dietary supplement |
| 03/05/2013 | US8389503 Steroidal antitubercular compounds |
| 03/05/2013 | US8389502 Stabilized steroid composition and method for its preparation |
| 03/05/2013 | US8389501 Anticancer compound |
| 03/05/2013 | US8389500 Fused heterocyclic compounds as ion channel modulators |
| 03/05/2013 | US8389499 Cyclodextrin-based polymers for therapeutics delivery |
| 03/05/2013 | US8389498 Spinning solution and method for manufacturing biomaterial fibers |
| 03/05/2013 | US8389497 Using of alkylphosphocholines for the manufacture of a drug product for the therapy of benign and malignant oncoses |
| 03/05/2013 | US8389495 Olioodeoxynucleotide and its use to induce an immune response |
| 03/05/2013 | US8389492 Lyophilized DNA formulations for enhanced expression of plasmid DNA |
| 03/05/2013 | US8389491 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same |
| 03/05/2013 | US8389487 siRNA-mediated gene silencing of synuclein |
| 03/05/2013 | US8389484 Methods for targeting RNA molecules |
| 03/05/2013 | US8389483 Diagnosis of fetal growth restriction; administering to mother hypotoinic glucose supplements |
| 03/05/2013 | US8389473 Treatment of cardiac arrhythmias |
| 03/05/2013 | US8389440 Synergistic insecticide mixtures |
| 03/05/2013 | US8389279 α-aminocyclolactam ligands for G-protein coupled receptors, and methods of using same |
| 03/05/2013 | US8389043 Preparation for restenosis prevention |
| 03/05/2013 | US8389026 Composition and method for skin repair |
| 03/05/2013 | US8389013 Process for producing particles via atomized rapid injection for solvent extraction |
| 03/05/2013 | US8389011 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/05/2013 | US8389006 Pharmaceutical compositions of adsorbates of amorphous drug |
| 03/05/2013 | US8389005 Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance |
| 03/05/2013 | US8389003 Ingestible implement for weight control |
| 03/05/2013 | US8388978 Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin |